The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. - Slaninová, Věra; Heron-Milhavet, Lisa; Robin, Mathilde; Jeanson, Laura; Aissanou, Adam; Kantar, Diala; Tosi, Diego; Bréhélin, Laurent; Gongora, Céline; Djiane, Alexandre (BMC Cancer, 2024)